Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,775.00
Bid: 1,700.00
Ask: 1,779.00
Change: 0.00 (0.00%)
Spread: 79.00 (4.647%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 1,775.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK BROKER RATINGS: Liberum Downgrades GlaxoSmithKline To Sell

Wed, 30th Jul 2014 09:03

LONDON (Alliance News) - The following UK shares received analyst recommendations Wednesday morning:
----------
FTSE 100
----------
SOCGEN CUTS NEXT PRICE TARGET TO 6737 (6820) PENCE - 'HOLD'
----------
TRADERS: NOMURA RAISES AB FOODS PRICE TARGET TO 2480 (2400) PENCE - 'REDUCE'
----------
BERENBERG RAISES REED ELSEVIER PRICE TARGET TO 960 (930) PENCE - 'HOLD'
----------
MORGAN STANLEY CUTS SAINSBURY TO 'EQUAL-WEIGHT' ('OVERWEIGHT')
----------
SOCGEN RAISES BP PRICE TARGET TO 550 (540) PENCE - 'BUY'
----------
DEUTSCHE BANK CUTS ROYAL MAIL PRICE TARGET TO 400 (486) PENCE - 'HOLD'
----------
LIBERUM CUTS GLAXOSMITHKLINE TO 'SELL' ('HOLD') - TARGET 1350 (1500) PENCE
----------
HSBC CUTS NEXT TO 'NEUTRAL' ('OVERWEIGHT') - TARGET 7350 PENCE
----------
UBS RAISES RECKITT BENCKISER PRICE TARGET TO 4550 (4450) PENCE - 'SELL'
----------
JPMORGAN RAISES GKN PRICE TARGET TO 460 (430) PENCE - 'OVERWEIGHT'
----------
DEUTSCHE BANK CUTS ST JAMES'S PLACE PRICE TARGET TO 925 (950) PENCE - 'BUY'
----------
JPMORGAN RAISES ST JAMES'S PLACE PRICE TARGET TO 924 (909) PENCE - 'OVERWEIGHT'
----------
CREDIT SUISSE RAISES SMITH & NEPHEW PRICE TARGET TO 890 (865) PENCE - 'NEUTRAL'
----------
NUMIS RAISES STANDARD CHARTERED TO 'ADD' ('HOLD') - TARGET 1400 (1340) PENCE
----------
CANACCORD RAISES BRITISH AMERICAN TOBACCO PRICE TARGET TO 2925 (2900) PENCE - 'SELL'
----------
FTSE 250
----------
HSBC INITIATES PHOENIX GROUP WITH 'OVERWEIGHT' - TARGET 825 PENCE
----------
BERENBERG CUTS THOMAS COOK PRICE TARGET TO 170 (200) PENCE - 'BUY'
----------
TRADERS: NOMURA CUTS BETFAIR TO 'REDUCE' ('NEUTRAL')
----------
LIBERUM CUTS PACE PLC PRICE TARGET TO 390 (420) PENCE - 'HOLD'
----------
JEFFERIES CUTS PACE PLC PRICE TARGET TO 425 (467) PENCE - 'BUY'
----------
BARCLAYS RAISES ELEMENTIS PRICE TARGET TO 246 (243) PENCE - 'UNDERWEIGHT'
----------
SOCGEN CUTS TULLETT PREBON PRICE TARGET TO 245 (305) PENCE - 'HOLD'
----------
HSBC RAISES TULLETT PREBON TO 'OVERWEIGHT' ('NEUTRAL') - TARGET 311 PENCE
----------
BARCLAYS CUTS TULLETT PREBON PRICE TARGET TO 265 (335) PENCE - 'EQUAL WEIGHT'
----------
UBS REMOVES TULLETT PREBON FROM 'LEAST PREFERRED LIST' DIVERSIFIED FINANCIAL
----------
UBS RAISES TULLETT PREBON TO 'NEUTRAL' ('SELL') - TARGET 250 (230) PENCE
----------
DEUTSCHE BANK RAISES RENTOKIL INITIAL PRICE TARGET TO 114 (109) PENCE - 'HOLD'
----------
NUMIS CUTS INFORMA PRICE TARGET TO 620 (645) PENCE - 'BUY'
----------
UBS CUTS INFORMA PRICE TARGET TO 500 (520) PENCE - 'NEUTRAL'
----------
BERENBERG CUTS INFORMA PRICE TARGET TO 520 (530) PENCE - 'HOLD'
----------
HSBC RAISES GREAT PORTLAND PRICE TARGET TO 737 (715) PENCE - 'OVERWEIGHT'
----------
JPMORGAN RAISES DIRECT LINE PRICE TARGET TO 270 (228) PENCE - 'NEUTRAL'
----------
JEFFERIES CUTS TATE & LYLE PRICE TARGET TO 685 (715) PENCE - 'HOLD'
----------
NUMIS CUTS HISCOX TO 'HOLD' ('ADD') - TARGET 710 (785) PENCE
----------
NUMIS RAISES RIGHTMOVE PRICE TARGET TO 3397 (3360) PENCE - 'BUY'
----------
CANACCORD CUTS JLT GROUP TO 'HOLD' ('BUY') - TARGET 1070 (1165) PENCE
----------
MAIN MARKET AND AIM
----------
JPMORGAN RAISES GEM DIAMONDS PRICE TARGET TO 235 (200) PENCE - 'OVERWEIGHT'
----------
By Arvind Bhunjun; arvindbhunjun@alliancenews.com; @ArvindBhunjun

Copyright 2014 Alliance News Limited. All Rights Reserved.


More News
17 Jan 2024 07:46

LONDON BRIEFING: UK inflation surprises as unexpectedly rises to 4.0%

(Alliance News) - Stocks in London are called to open lower on Wednesday, following some hotter-than-expected consumer price data from the UK.

Read more
17 Jan 2024 07:31

GSK raises $1.24 bln from latest Haleon stake sale

Jan 17 (Reuters) - GSK has raised 978 million pounds ($1.24 billion) from a discounted sale of a stake in its spun-off consumer healthcare business Haleon, the British drugmaker said on Wednesday.

Read more
16 Jan 2024 17:04

GSK to sell GBP1 billion worth of Haleon shares as trims stake again

(Alliance News) - GSK PLC on Tuesday said it intends to sell around GBP1.00 billion worth of shares in Haleon PLC, as it continues to reduce its shareholding in the Weybridge, Surrey-based consumer healthcare spin-off.

Read more
16 Jan 2024 09:14

LONDON BROKER RATINGS: UBS raises GSK and cuts AstraZeneca

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
16 Jan 2024 08:15

UBS downgrades AstraZeneca to 'sell'

(Sharecast News) - UBS has downgraded AstraZeneca and upgraded rival GSK as part of its latest review of the European pharmaceutical sector.

Read more
16 Jan 2024 07:37

LONDON BRIEFING: UK jobless rate sticks at 4.2% but pay growth slows

(Alliance News) - Stocks in London are called to open lower on Tuesday, following data showing that the UK jobless rate was unchanged at 4.2% as pay growth slowed.

Read more
15 Jan 2024 08:42

Zantac fallout unfairly weighing on GSK, says Shore Capital

(Sharecast News) - Shore Capital has raised its target price and maintained a positive stance on biopharma giant GSK, saying that worries about the potential cost of Zantac litigation are unfairly weighing on the stock.

Read more
10 Jan 2024 09:35

LONDON BROKER RATINGS: BofA cuts Ashtead; UBS likes 3i Group

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
10 Jan 2024 08:25

GSK says Nucala gets green light in China for asthma treatment

(Alliance News) - GSK PLC on Wednesday said Nucala has been approved in China for the treatment of severe asthma.

Read more
10 Jan 2024 07:22

GSK's Nucala gets fresh approval in China

(Sharecast News) - GSK announced on Wednesday that the China National Medical Products Administration (NMPA) has granted approval for 'Nucala', or mepolizumab, as an add-on maintenance treatment for severe eosinophilic asthma in adults and adolescents aged 12 years and older.

Read more
9 Jan 2024 16:22

London close: Stocks finish red after choppy session

(Sharecast News) - London stocks had turned back into the red by the close on Tuesday, with recruitment firms and asset managers pacing the declines after some disappointing corporate updates.

Read more
9 Jan 2024 08:03

TOP NEWS: GSK to buy Aiolos Bio for up to USD1.4 billion

(Alliance News) - GSK PLC on Tuesday said it will acquire asthma drug developer Aiolos Bio Inc for USD1 billion upfront, as well as up to USD400 million in certain success-based milestone payments.

Read more
9 Jan 2024 07:16

GSK buys respiratory drug maker Aiolos for $1bn

(Sharecast News) - GSK said it was buying Aiolos, a clinical-stage biopharmaceutical company focused on treatment of respiratory and inflammatory conditions, for up to $1.4bn (£1.1bn).

Read more
8 Jan 2024 23:39

Pfizer to remain aggressive on obesity market after setback

NEW YORK, Jan 8 (Reuters) - Pfizer will remain aggressive in trying to break into the lucrative obesity market, even after dropping a high profile weight-loss drug candidate late last year due to strong side effects, Chief Executive Albert Bourla said on Monday.

Read more
8 Jan 2024 23:00

Pfizer to remain aggressive on obesity market after setback

NEW YORK, Jan 8 (Reuters) - Pfizer will remain aggressive in trying to break into the lucrative obesity market, even after dropping a high profile weight-loss drug candidate late last year due to strong side effects, Chief Executive Albert Bourla said on Monday.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.